Zhejiang Huakang Pharmaceutical Co., Ltd.SSE: 605077

Semi-annual Performance Forecast for 2026

· Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The company expects to achieve a net profit attributable to shareholders within a specified range, which reflects a substantial decrease from the prior period. The forecast highlights that the anticipated decrease in profit is primarily due to changes in product sales structure and increased financial expenses. Investors are cautioned that these figures are preliminary and have not been audited, with final results to be disclosed in the official report.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huakang Pharmaceutical

Later from Zhejiang Huakang Pharmaceutical

All Zhejiang Huakang Pharmaceutical news releases